PRECISION BIOSCIENCES INC (DTIL) Operating cash flow 2018–2025
PRECISION BIOSCIENCES INC (DTIL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$65.8MFY2025 · since FY2018: -$51.7M → -$65.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.8M | -12.7% |
| FY2024 | -$58.4M | +30.5% |
| FY2023 | -$84.1M | -83.8% |
| FY2022 | -$45.8M | -321.6% |
| FY2021 | -$10.9M | +87.6% |
| FY2020 | -$87.4M | -23.1% |
| FY2019 | -$71.0M | -37.3% |
| FY2018 | -$51.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DTIL financial trends
DTIL RevenueDTIL Net incomeDTIL Net marginDTIL Gross profitDTIL Gross marginDTIL Operating incomeDTIL Operating marginDTIL Free cash flowDTIL Capital expendituresDTIL Return on equityDTIL Stock buybacksDTIL Dividends paidDTIL Total assetsDTIL Total liabilitiesDTIL Shareholders’ equityDTIL overview →